Physician profile
Ryan M Dahlgren
NPI 1215133871
$7,045.58
in general payments reported to CMS, 2019-2025
14 companies · $236 in 2025
The $236 reported for 2025 was less than what a typical Neuroradiology provider received nationally (typical 2025 total: $278).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,415 · 2020: $264 · 2021: $1,198 · 2022: $1,051 · 2023: $668 · 2024: $213 · 2025: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,117.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,545.05 | 2019-2025 | Pod, Penumbra System, Benchmark |
| Stryker Corporation | $1,781.15 | 2019-2025 | Target, Surpass Evolve, Axs Infinity Ls |
| Microvention, INC. | $556.95 | 2020-2022 | |
| Medtronic USA, INC. | $274.53 | 2019-2020 | |
| Imperative Care, INC | $245.95 | 2022-2024 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter |
| Medtronic, INC. | $220.87 | 2021-2024 | Pipeline |
| Alexion Pharmaceuticals, INC. | $125.87 | 2022 | |
| Siemens Medical Solutions USA, INC. | $125.66 | 2023 | Artis Q Floor |
| Astrazeneca Pharmaceuticals LP | $46.47 | 2021-2022 | |
| Biogen, INC. | $43.17 | 2021 | |
| Integra Lifesciences Corporation | $31.49 | 2019 | |
| Arteriocyte Medical Systems, INC. | $19.00 | 2022 | |
| Depuy Synthes Sales INC. | $16.34 | 2022 | |
| Chiesi USA, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Dahlgren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.